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Abstract: 
Objective: To evaluate the efficacy and operator satisfaction of Endosampler in endometrial sampling for the 
diagnosis of endometrial cancer.  
Study Design: A Non Randomized Experimental Trial. 
Place and Duration of Study: The Department of Obstetrics and Gynecology Bahawal Victoria Hospital, 
Bahawalpur.  From 15 July 2015 to 10 December 2017 
Methodology: overall 300 patients were selected for study. Data was collected regarding demographic 
informations like age, parity and outcome variable as operator satisfaction, positive and negative sampling. 
Collected data information was entered in SPSS version 24 for mean ± SD calculation of numerical data (age 
and parity) frequency percentages of categorical variables operator satisfaction, positive and negative sampling 
was calculated. Student t test was applied on data and p value ≤0.05 was considered as significance.  
Results: Among studied patents operative satisfaction score (ranged 1-5) was 1-2 73.7% well accepted. While, 
Operative satisfaction score was ranged 3-5, 26.3% poorly accepted. Positive sampling was 82.7%.While 
negative sampling was 17.3%. No association was found between operative satisfaction score and sampling.  
Conclusion: Our results revealed that Endosampler is a useful device for endometrial sampling for the diagnosis 
of endometrial cancer with high rate of operator satisfaction. 
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Introduction: 
In case of endometrial cancers Dilatation and curettage (D and C) is a useful technique for solicitation of 
endometrium for severe uterine bleeding1. From a long time this technique considered as gold standard among 
lot of modalities for this purpose
2
. When someone concern about its disadvantages, use of Operation Theater and 
requirement of general and regional anesthesia are main disadvantages of D and C. D and C is a time taking 
procedure with consequent cost and has lot of complications from local anesthetics
3
. Taking these complications 
in consideration D and C was replaced with many other outpatient techniques. 
Abnormal uterine bleeding is an initial sign in suspected cases of endometrial cancer patients, for diagnostic 
purpose transvaginal ultrasound to measure the endometrial thickness is an primaey investigation and 
procedure
4
. Endometrial thickness of 5 mm in postmenopausal women is a standard but in non menopausal 
ladies endometrial thickness is under debate and time of ultrasound is also fixed as close to bleeding episode as 
possible. in patients with history of recurrent bleeding
5
, diagnosed polyps and endometrial thickness above these 
values (4,5 mm in non menopausal women) histipathology must be performed for confirmation of diagnosis. 
Point to be noted that advance endometrial cancer was noted in patients whom endometrial thickness is ≤ 5 mm, 
such patients must have histological sampling6. 
Sampling of endometrium was performed in previous days with disposable devices and these studies were 
conducted to evaluate their effectiveness7. Due to time limitations and small number of patients for studies 
efficacy of one method not declared over other
8
. Superiority of these techniques needs more investigation and 
large sample scale studies. Not all available studies conducted for diagnostic accuracy of sampling technique
9
. In 
recent era a new technique famous with name of endosampler is available in form of disposable device which is 
a joint venture of Lombard ILL and MedGynand easy to use for sampling of endometrium 10. In our study we 
aim to investigate the diagnostic yield of Endosampler for endometrial sampling in suspected cases of 
endometrial cancer.  
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Methodology: 
 This non randomized trial was conducted in the department of Obstetrics and Gynecology Bahawal Victoria 
Hospital, Bahawalpur. From 15 July 2015 to 10 December 2017 under supervision of senior Hospital and 
Department staff. Non probability consecutive sampling technique was used. Total number of 300 patients who 
were suspected cases of endometrial cancer selected for study. Endometrial samples were obtained before 
decision of hysterectomy. Patients with previous history of endometrial sampling and who were refused to give 
consent were excluded from the study.  
Endosampler is a 23 cm long plastic portable device with 3 mm external diameter. At the round tip of device 
there is 4 mm hole which represents its mouth opening. Shape of this end is like curette (not round not flushed 
with tube).   
Fig-A 
 
Endosampler Device 
An angle of 160 degree is also given from the tip to adjust according the anatomy of uterus. This angle is six cm 
from the tip of device. A base point is given to attach 5 ml syringe to create negative pressure. Negative pressure 
can be maintained on detaching syringe by locking the spring structure made inside. Once negative pressure was 
maintained device can be detached from the cavity. It is very important to measure the uterine length before 
insertion of device to unlock the piston. Contents in the piston pushed into the container filled with formalin 
solution. All samples were analyzed by the same person who was unaware of device used for sampling. After 
that samples were confirmed with histopathology. Collected data information was entered in SPSS version 24 for 
mean ± SD calculation of numerical data (age and parity) frequency percentages of categorical variables 
(operator satisfaction, positive and negative sampling) was calculated. Chi square test was applied on data and p 
value ≤0.05 was considered as significance. 
Results: 
 Overall, 300 patients were enrolled in this study. The mean age and parity of the patients was 
44.03±2.38 years and 1.95±0.95 respectively. The difference was statistically insignificant. (Table. I). 
 Operative satisfaction score (ranged 1-5) was 1-2 73.7% well accepted. While, Operative satisfaction 
score was 3-5, 26.3% poorly accepted. (Table.II). Positive sampling was 82.7%, while, negative sampling was 
17.3%.  (Figure.I). No association was found between operative satisfaction score and sampling. (Table.III). 
Table-I 
 Demographic characteristics of the patients 
Variable Presence Test of Sig. 
Age (years) 44.36±5.40 t=0.325, p=0.745 
Parity 1.95±0.95 t=-0.236, p=0.814 
Table. II 
Operator satisfaction score 
Variable Frequency Percentage 
1-2 well accepted 221 73.7 
3-5 poorly accepted 79 26.3 
Total 300 100.0 
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Table. III 
Association of Operator satisfaction score and sampling 
Operative satisfaction score Sampling Total Chi-Square 
P-value 
Positive 
sampling 
Negative 
sampling 
 well accepted 
182 39 221 
0.810 poorly accepted 
66 13 
79 
Total 
248 52 
300 
 
Figure. I 
 
Figure. II 
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Discussion: 
Office endometrial sampling is a preferable and commonly accepted procedure used to diagnose endometrial 
pathology, mainly due to its economical cost, minimal theatre time and ward admission 11. Moreover, the 
efficacy of endometrial devices commonly calculated as yield for endometrial carcinoma and hyperplasia is 
almost comparable to the classical D and C 
12
. General anesthesia required for D & C is avoidable by using 
office endometrial sampling techniques which can be carried out with or without local anesthesia. Last but not 
the least, the ease of its use during first clinical visit helps in reducing the time to reach at a diagnosis. The best 
device competition for office endometrial sampling has been a tough race and a hot topic of many researchers. 
The parameters used to reach a conclusion regarding this race include the simplicity in use, comfort level of the 
patient, low cost e minimal major complications and good tissue yield for histopathological evaluation.  
In our study, the mean age and parity of the patients was 44.03±2.38 years and 1.95±0.95 respectively. Operative 
satisfaction score was ranked on a range of 1-5. In 73.7% cases it was well accepted and poorly accepted in 
remaining 26.3% of cases. Positive sampling was 82.7% while, negative sampling was 17.3%. No association 
was found between operative satisfaction score and sampling.  
Accuracy of a positive test result is high but that of a negative test result is of limited value. Thus, a negative test 
is not accurate enough to rule out the need of further diagnostic testing, thereby reducing the utility of outpatient 
biopsy in isolation for excluding disease 
13
. Poor patient compliance or biopsy technique can give rise to 
inadequate endometrial samples and may lead to non-representative sampling. Endometrial carcinoma can be 
missed in outpatient biopsy. Therefore, if intrauterine structural abnormalities are suspected or symptoms persist 
than transvaginal ultrasonography, outpatient hysteroscopy and further endometrial sampling or a combination of 
these can be used to reach at a confirmed diagnosis
 14,15,16,17
.  
Most other studies give a comparison of Pipelle with the Endosampler in a randomised fashion. Endosampler 
seem to be easier to use than pipelle. No major complications are associated with any of this device. Efficacy of 
any endometrial sampler device seems to be in direct relation with the size of the endometrium excised as 
biopsy, making the Endosampler a better device than the Pipelle with a p-value of 0.03 
18
. A study done by 
Rodriguez et al showed that the percentage of sampled endometrium obtained by using Vabra aspirator was also 
higher than that of Pipelle with p-value  of < 0.001 19. 
 A formal D and C can also fail to detect malignant change of the endometrium. This failure to detect 
malignancy is not limited to patients undergoing outpatient sampling 
20,21
. Detection of polyps by Blind 
endometrial sampling is unreliable
22
. Endometrial samples obtained by endosampler showed no noticeable 
abnormalities.  
If clinician correlates the clinical findings with the endometrial sampling findings, especially the endosampler 
owing to its higher adequacy of  sample size, can pick up the missed endometrial carcinoma by repeated 
sampling through a different technique.
11
 
Conclusion: 
Our results revealed that Endosampler is a useful device for endometrial sampling for the diagnosis of 
endometrial cancer with high rate of operator satisfaction. 
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